Compare SLVM & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLVM | BHVN |
|---|---|---|
| Founded | 1898 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 2021 | 2022 |
| Metric | SLVM | BHVN |
|---|---|---|
| Price | $42.15 | $9.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $54.00 | $29.08 |
| AVG Volume (30 Days) | 341.3K | ★ 2.0M |
| Earning Date | 05-08-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.31% | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ 3.24 | N/A |
| Revenue | ★ $3,351,000,000.00 | N/A |
| Revenue This Year | $0.98 | N/A |
| Revenue Next Year | $2.28 | N/A |
| P/E Ratio | $12.90 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $37.09 | $7.48 |
| 52 Week High | $62.02 | $24.06 |
| Indicator | SLVM | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 48.76 | 46.02 |
| Support Level | $41.56 | $8.08 |
| Resistance Level | $43.81 | $10.22 |
| Average True Range (ATR) | 1.29 | 0.63 |
| MACD | 0.44 | 0.15 |
| Stochastic Oscillator | 84.71 | 54.93 |
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills. It produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers, and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.